Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1/Phase 2"
topic_facet:"Medical Condition: ;Neoplasms"
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%3BNeoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%3BNeoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2FPhase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+%3BNeoplasms%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (42)
1
Prevention of post-ESD esophageal stricture by fluticasone inhaler administration: a single-arm, pilot study : Prevention of post-ESD esophageal stricture by fluticasone inhaler administration: a single-arm, pilot study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Prevention of post-ESD esophageal stricture by fluticasone inhaler administration: a single-arm, pilot study : Prevention of post-ESD esophageal stricture by fluticasone inhaler administration: a single-arm, pilot study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpression : Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpression : Phase 1b/2 trial for CKD-702 in combination with irinotecan as a third-line therapy for gastric cancer with MET or EGFR protein overexpression
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A phase IB/II study of abemaciclib with paclitaxel for CDK4/6 pathway activated tumors : An open-label, multi-center phase IB/II study of abemaciclib with paclitaxel for CDK4/6 pathway activated tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a second-line therapy for recurrent / progressive gastric cancer with INCB054828 and paclitaxel a study to evaluate the safety and efficacy of combination therapy. : An Open Label, Single-Arm, Multi-center Phase Ib/II Study to Evaluate the Safety and Efficacy of INCB054828 in Combination with Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer with Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A phase IB/II study of abemaciclib with paclitaxel for CDK4/6 pathway activated tumors : An open-label, multi-center phase IB/II study of abemaciclib with paclitaxel for CDK4/6 pathway activated tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a second-line therapy for recurrent / progressive gastric cancer with INCB054828 and paclitaxel a study to evaluate the safety and efficacy of combination therapy. : An Open Label, Single-Arm, Multi-center Phase Ib/II Study to Evaluate the Safety and Efficacy of INCB054828 in Combination with Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer with Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Clnical trial to Evaluate the Safety and Efficacy of Pertuzumab Plus Trastuzumab Plus Docetaxel Combination with MYJ1633 (Autologous Blood-Derived Lymphocytes) in HER-2 Positive Breast Cancer Patients : Double-arm, Open, Parallel Assignment, Sponsor-Initiated Trial to Evaluate the Safety and Efficacy of Pertuzumab Plus Trastuzumab Plus Docetaxel Combination with MYJ1633 (Autologous Blood-Derived Lymphocytes) in Recurrent Nonresectable or Metastatic HER-2 Positive Breast Cancer Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Clnical trial to Evaluate the Safety and Efficacy of Pertuzumab Plus Trastuzumab Plus Docetaxel Combination with MYJ1633 (Autologous Blood-Derived Lymphocytes) in HER-2 Positive Breast Cancer Patients : Double-arm, Open, Parallel Assignment, Sponsor-Initiated Trial to Evaluate the Safety and Efficacy of Pertuzumab Plus Trastuzumab Plus Docetaxel Combination with MYJ1633 (Autologous Blood-Derived Lymphocytes) in Recurrent Nonresectable or Metastatic HER-2 Positive Breast Cancer Patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1/Phase 2
Filter aufheben
Thema: Medical Condition: ;Neoplasms
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
42
Aufsätze
42
E-Artikel
42
E-Ressourcen
Zeitschriftentitel
42
WHO International Clinical Trials Registry Plat...
Thema
42
610
Medical Condition: ;Neoplasms
Phase: Phase 1/Phase 2
Recruitment Status: Recruiting
42
Study Type: Interventional
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
24
2020-
18
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
42
Englisch
Haven't found what you're looking for?
Wird geladen...